| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | alpha-ketoglutarate | 46 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 79 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 79 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 87 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 104 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 109 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 118 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 131 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 180 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 185 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 188 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 238 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 315 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 360 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 417 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 481 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 506 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 510 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 530 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 538 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 543 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 550 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 561 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 601 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 747 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 766 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 774 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 787 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 819 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 846 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 869 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 874 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 916 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 976 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1018 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1075 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1100 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1122 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1131 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1464 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1725 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1746 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1827 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1882 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1923 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 1962 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 2244 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 2693 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 2910 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 2985 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 3476 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 3726 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 22513 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | alpha-ketoglutarate | 30551 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|